Tuas, Singapore: ESC is pleased to announce that one of the world’s largest pharmaceutical companies, via their selected EPC, commissioned ESC to carry out Permitting Support for the erection of a new pilot plant in Tuas. The Singapore site will strengthen the client’s manufacturing capacities and expected to become a regional innovation hub for the healthcare industry in Asia.
As part of the local regulatory requirements for setting up new facilities, all companies in Singapore must carry out a Quantitative Risk Assessment (QRA) study in compliance with the Major Hazard Department (MHD), National Environment Agency (NEA), and Environmental Baseline Study (EBS) by Jurong Town Council (JTC).
ESC is involved in the planning and preliminary design stages of the project. In the planning stage, ESC provided general advisory matters including timeline expectations for each of the approvals from various Singapore authorities, and clarifications to facilitate the QRA process. In preliminary design, ESC carried out the necessary internal assessment and liaise with Singapore authorities to obtain the in-principle approval within the expected timeline.
ESC is approved by Singapore’s Agencies to conduct QRA, PCS, and EBS studies. Leveraging our established professional relationships with regulatory authorities, ESC was able to provide the client with an understanding of how the facility is managed, to design in-depth defence, to understand any limits on operating the facility, and to identify issues that require further investigation.